Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement
| Autor: | Daniel S. Pratt, Elizabeth C. Verna, Jorge A. Bezerra, Ryan M. Kwok, Rohit Loomba, Oren K. Fix, Raymond T. Chung, K. Rajender Reddy, Michael L. Schilsky, Mark W. Russo, David C. Mulligan, Brendan M. McGuire, David E. Cohen, Robert J. Fontana, Bilal Hameed |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Original medicine.medical_treatment coronavirus Comorbidity Liver transplantation Medical Biochemistry and Metabolomics SARS‐CoV‐2 Oral and gastrointestinal Liver disease 0302 clinical medicine Pandemic Global health Drug Interactions Viral immunosuppression Liver Diseases Liver Disease Gastroenterology Tissue Donors Practice Guidelines as Topic 030211 gastroenterology & hepatology Patient Safety Coronavirus Infections medicine.medical_specialty Consensus Best practice Pneumonia Viral Clinical Sciences Immunology MEDLINE 03 medical and health sciences Patient safety Betacoronavirus Clinical Research Internal medicine medicine Humans Intensive care medicine Pandemics Occupational Health Immunosuppression Therapy Transplantation Hepatology Gastroenterology & Hepatology business.industry SARS-CoV-2 cirrhosis Internship and Residency COVID-19 Pneumonia Organ Transplantation medicine.disease Liver Transplantation COVID-19 Drug Treatment 030104 developmental biology Emerging Infectious Diseases Good Health and Well Being business Digestive Diseases transplantation |
| Zdroj: | Hepatology (Baltimore, Md.), vol 72, iss 1 Hepatology Hepatology (Baltimore, Md.) |
| Popis: | Background and aims Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers. Approach and results This article discusses what is known about COVID-19 with a focus on its impact on hepatologists, liver transplant providers, patients with liver disease, and liver transplant recipients. We provide clinicians with guidance for how to minimize the impact of the COVID-19 pandemic on their patients' care. Conclusions The situation is evolving rapidly, and these recommendations will need to evolve as well. As we learn more about how the COVID-19 pandemic impacts the care of patients with liver disease, we will update the online document available at https://www.aasld.org/about-aasld/covid-19-and-liver. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|